0
Department of Health and Human Services Awarded a Contract to NEW YORK GENOME CENTER, INC. for $149,000,000.00
Signed on
1/30/2023, 12:00 AM
NEW YORK GENOME CENTER, INC. Government Contract #75N95023D00007
NEW YORK GENOME CENTER, INC. was awarded a contract with the United States Government for $149,000,000.00. The contract was awarded by the agency office NATIONAL INSTITUTES OF HEALTH NIDA, which is a division with the National Institutes of Health within the Department of Health and Human Services.
Summary of Award
The US federal government awarded a contract to the New York Genome Center, Inc. for the Brain Initiative Cell Atlas Network (BICAN) Sequencing Core Task Areas 1 through 7. The contract falls under the category of Indefinite Delivery / Indefinite Quantity (IDIQ) with a maximum value of $149,000,000 and a minimum of $10,000 per awardee. The task ordering period is from January 23, 2023, to January 22, 2038.
The contract was signed on January 30, 2023, by the Department of Health and Human Services, specifically the National Institutes of Health (NIH). The contract type is an Indefinite Delivery Contract (IDC) with full and open competition. The contract is for Health R&D services, health care services, and basic research, falling under the product or service code AN11 and NAICS code 541714 for Research and Development in Biotechnology.
The recipient of the contract, the New York Genome Center, Inc., is a U.S.-owned business located in New York City. They are a corporate entity tax-exempt nonprofit organization not designated as a small business. The recipient's parent organization is also the New York Genome Center, Inc.
The contract's period of performance is from January 31, 2023, to January 30, 2030, with a last modified date of January 31, 2025. The contract does not involve any subcontracting possibilities, and the pricing arrangement is order-dependent.
The contract does not involve any outlays or obligations at the time of the report. The funding agency is the Department of Health and Human Services, specifically the National Institutes of Health, while the awarding agency is the National Institutes of Health NIDA.
Overall, the contract awarded to the New York Genome Center, Inc. for the BICAN Sequencing Core Task Areas 1 through 7 is a significant investment in research and development in biotechnology, health care services, and basic research. The contract's value and duration indicate a long-term commitment to advancing scientific knowledge and innovation in these areas.